Journal Information
Vol. 75. Issue 02.
Pages 131-134 (March - April 1999)
Share
Share
Download PDF
More article options
Vol. 75. Issue 02.
Pages 131-134 (March - April 1999)
Full text access
Deficiência de ornitina transcarbamilase: diagnóstico neonatal
Visits
4176
Cristina A. G. Ulhôaa, Cynthia T. Barrettb
a Fellow em CTI Neonatal - UCLA (Universidade da Califórnia Los Angeles).
b Professora, Chefe de Neonatologia e CTI-Neonatal na UCLA (Universidade da Califórnia, Los Angeles).
This item has received
Article information
Abstract
Objective

To draw pediatricians' attention to an enzyme deficiency in the urea cycle, as the prognosis of this disease is directly related to early diagnosis and treatment. Methods: We describe the case of a newborn who presented with lethargy, vomit and seizures 48 hours after birth. After examination, we diagnosed ornithine transcarbamylase deficiency. Treatment was started immediately. Results: We followed up the patient until he was 1 year old, when he underwent liver transplantation. Outcome was good. Conclusion: Ornithine transcarbamylase deficiency is a rare and very serious disease. Any newborn whose evolution is similar to that of a septic patient but has no infection must be investigated for this disease. Prognosis is directly related to early diagnosis and treatment.

Methods

We describe the case of a newborn who presented with lethargy, vomit and seizures 48 hours after birth. After examination, we diagnosed ornithine transcarbamylase deficiency. Treatment was started immediately. Results: We followed up the patient until he was 1 year old, when he underwent liver transplantation. Outcome was good. Conclusion: Ornithine transcarbamylase deficiency is a rare and very serious disease. Any newborn whose evolution is similar to that of a septic patient but has no infection must be investigated for this disease. Prognosis is directly related to early diagnosis and treatment.

Results

We followed up the patient until he was 1 year old, when he underwent liver transplantation. Outcome was good. Conclusion: Ornithine transcarbamylase deficiency is a rare and very serious disease. Any newborn whose evolution is similar to that of a septic patient but has no infection must be investigated for this disease. Prognosis is directly related to early diagnosis and treatment.

Conclusion

Ornithine transcarbamylase deficiency is a rare and very serious disease. Any newborn whose evolution is similar to that of a septic patient but has no infection must be investigated for this disease. Prognosis is directly related to early diagnosis and treatment.

Resumen
Objetivo

Alertar os pediatras para a deficiência de enzimas do ciclo da uréia. Essa patologia deve ser lembrada, pois o prognóstico do recém-nascido está diretamente relacionado com a precocidade do diagnóstico e a instituição de uma terapêutica adequada.

Método

Apresentamos um paciente que, após 48 horas de vida, iniciou com quadro de sonolência, letargia, vômitos e convulsão, tendo-se pensado, inicialmente, em sepsis neonatal. Após excluído esse diagnóstico, foi diagnosticada deficiência de ornitina transcarbamilase (OTC).

Resultado

O paciente foi tratado e acompanhado até a idade de um ano, quando foi submetido ao transplante hepático com boa evolução e controle da doença.

Conclusão

A deficiência de ornitina transcarbamilase (OTC), é rara, porém muito grave. O recém-nascido que apresentar um quadro clínico semelhante ao de um recém-nascido séptico, porém sem contexto infeccioso, deve ser investigado para essa patologia, pois o prognóstico está diretamente relacionado com a rapidez do diagnóstico e do tratamento.

Full text is only available in PDF
Download PDF
Idiomas
Jornal de Pediatria (English Edition)
Article options
Tools
en pt
Taxa de publicaçao Publication fee
Os artigos submetidos a partir de 10 de fevereiro de 2025, que forem aceitos para publicação no Jornal de Pediatria, estarão sujeitos a uma taxa para que tenham sua publicação garantida. Ao submeterem o manuscrito a esta revista, os autores concordam com esses termos. A submissão dos manuscritos continua gratuita. Effective February 10, 2025, all articles submitted will be subject to an Article Publishing Charge (APC) after peer review and acceptance. By submitting the manuscript to this journal, the authors agree to these terms. Manuscript submission remains free of charge.
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.